BioMark Diagnostics Inc.
BMKDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $35,092 | $32,089 | $23,442 | $17,676 |
| - Cash | $722 | $212 | $2,482 | $89 |
| + Debt | $153 | $359 | $454 | $547 |
| Enterprise Value | $34,524 | $32,237 | $21,415 | $18,134 |
| Revenue | $7 | $39 | $39 | $39 |
| % Growth | -82.4% | 0% | 1.1% | – |
| Gross Profit | $7 | $39 | $39 | $39 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$389 | -$306 | -$184 | -$262 |
| % Margin | -5,654.3% | -785.8% | -471.3% | -678.3% |
| Net Income | -$481 | -$416 | -$422 | -$335 |
| % Margin | -7,006.2% | -1,066.9% | -1,082.1% | -868.1% |
| EPS Diluted | -0.01 | -0.004 | -0.005 | -0.004 |
| % Growth | -150% | 16.7% | -23.1% | – |
| Operating Cash Flow | -$482 | -$286 | -$452 | -$190 |
| Capital Expenditures | -$9 | -$2 | -$1 | $0 |
| Free Cash Flow | -$491 | -$288 | -$453 | -$190 |